Pharma-Natural Recalls Tusslin Cough Syrup Due to Manufacturing Violations
Pharma-Natural Inc. is recalling Tusslin cough syrup because it was manufactured with current good manufacturing practice violations, including a lack of process validation.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, and the source text describes manufacturing deviations without reporting specific illnesses or injuries, fitting the criteria for a moderate severity voluntary precautionary recall.
Plain-English summary
Pharma-Natural Inc. is recalling 8,340 bottles of Tusslin (Dextromethorphan HBr, 28 mg; Guaifenesin, 388 mg; Phenylephrine HCl, 10 mg) in each 5 mL tsp, Grape Flavor, 16 Fl.oz. (474 mL) bottle. The product is identified by NDC 52083-622-16 and includes all lots remaining within expiry.
The recall was initiated due to current good manufacturing practice (CGMP) deviations. Specifically, the products were manufactured with a lack of process validation, cleaning validation, stability studies, and other CGMP violations.
The affected product was distributed to consignees in Florida and Texas, who may have further distributed it nationwide in the USA and Puerto Rico. Consumers should check their medicine cabinets for this specific product and stop using it if found.
The recalled product
- Product
- TUSSLIN (Dextromethorphan HBr, 28 mg; Guaifenesin, 388 mg; Phenylephrine HCl, 10 mg) in each 5 mL tsp, Grape Flavor, 16 Fl.oz. (474 mL) bottle, Kramer Novis, San Juan, PR 00917, NDC 52083-622-16.
- Manufacturer
- Pharma-Natural Inc.
- Category
- Drug — Cough and Cold
- Affected units
- 8,340
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- All lots remaining within expiry.
Distribution
Part of a larger recall action
This product is one of 16 recalled by Pharma-Natural Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 16 products in this recall →Related recalls
Same manufacturer · Pharma-Natural Inc.
See all →- ModeratePharma Natural Biotin 5000 mcg Dietary Supplement Recalled for Sub-Potency
FDA (Food) · 2023-10-04
- ModeratePharma-Natural Recalls LidoAID Gel Due to Manufacturing Violations
FDA (Drugs) · 2019-07-31
- ModeratePharma-Natural Recalls AbeeMed Cream Due to Manufacturing Violations
FDA (Drugs) · 2019-07-31
- ModeratePharma-Natural Recalls SORBUGEN Cough Syrup Due to Manufacturing Violations
FDA (Drugs) · 2019-07-31
- ModerateLido E.R. Lidocaine Cream Recalled for Manufacturing Violations
FDA (Drugs) · 2019-07-31
Same hazard · cgmp violations
See all →- ModeratePharma-Natural Recalls Dayma Pain Gel for Manufacturing Violations
FDA (Drugs) · 2019-07-31
- SeverePharma-Natural Recalls Double Tussin DM Due to Manufacturing Violations
FDA (Drugs) · 2019-07-31
Similar recalls
- HighCough Relief Medication Recalled for Non-Food Grade Lubricant Manufacturing Defect
FDA (Drugs) · 2023-06-07
- LowPoly Pharmaceuticals Recalls Poly-Tussin AC Liquid Due to Labeling and Specification Issues
FDA (Drugs) · 2014-07-23
- HighGuaifenesin and Dextromethorphan Cough Syrup Recalled for Manufacturing Control Deviations
FDA (Drugs) · 2022-09-14
- LowAaron Industries Recalls Tussin DM Cough Syrup Due to Precipitate
FDA (Drugs) · 2014-05-07
- HighCough medicine recalled due to manufacturing process deviation with non-food lubricant
FDA (Drugs) · 2023-06-07
- HighGuaifenesin-Dextromethorphan Cough Syrup Recalled for Failed Impurity Specifications
FDA (Drugs) · 2024-11-27